B. Sigal‐Zafrani

A. Vincent-Salomon, K. Muller, S. Neuenschwander, 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapy.

A. Vincent-Salomon, J. Klijanienko, C. Rosty, 2004, European journal of cancer.

Overexpression/Amplification of HER-2/neu is Uncommon in Invasive Carcinoma of the Uterine Cervix

A. Vincent-Salomon, C. Rosty, X. Sastre-Garau, 2004, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Intratumoral heterogeneity of HER2/neu expression and its consequences for the management of advanced breast cancer.

A. Vincent-Salomon, J. Pierga, V. Diéras, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Challenging single- and multi-probesets gene expression signatures of pathological complete response to neoadjuvant chemotherapy in breast cancer: experience of the REMAGUS 02 phase II trial.

M. Mathieu, B. Asselain, M. Marty, 2013, Breast.

Familial Breast Cancer: Clinical Response to Induction Chemotherapy or Radiotherapy Related to BRCA1/2 Mutations Status

B. Asselain, D. Stoppa-Lyonnet, A. Fourquet, 2009, American journal of clinical oncology.

A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients

M. Espié, M. Mathieu, M. Marty, 2010, Breast Cancer Research and Treatment.

Long-term outcome of the REMAGUS 02 trial, a multicenter randomised phase II trial in locally advanced breast cancer patients treated with neoadjuvant chemotherapy with or without celecoxib or trastuzumab according to HER2 status.

M. Espié, M. Mathieu, F. Reyal, 2017, European journal of cancer.

UvA-DARE ( Digital Academic Repository ) External Validation of Adjuvant ! Online Breast Cancer Prognosis Tool Prioritising Recommendations for Improvement

M. J. van de Vijver, H. Horlings, A. Vincent-Salomon, 2012 .

Urokinase-type plasminogen activator and plasminogen-activator-inhibitor type 1 predict metastases in good prognosis breast cancer patients.

A. Vincent-Salomon, M. Bollet, F. Reyal, 2009, Anticancer research.

8p22 MTUS1 Gene Product ATIP3 Is a Novel Anti-Mitotic Protein Underexpressed in Invasive Breast Carcinoma of Poor Prognosis

A. Vincent-Salomon, O. Delattre, F. Radvanyi, 2009, PloS one.

Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation

A. Ashworth, A. Vincent-Salomon, D. Stoppa-Lyonnet, 2010, British Journal of Cancer.

Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells.

J. Thiery, A. Vincent-Salomon, F. Bidard, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines.

J. Peterse, I. Ellis, C. Elston, 2003, European journal of cancer.

Risk of Second Non Breast Malignancies (SNBM) in Relation to Brca1 And Brca2 Mutation Status Following Breast-Conserving Surgery and Radiotherapy

A. Fourquet, A. Savignoni, Y. Kirova, 2006 .

Management of Operable Invasive Breast Cancer in Women Over the Age of 70: Long-Term Results of a Large-Scale Single-Institution Experience

B. Asselain, A. Savignoni, T. Dorval, 2010, Annals of Surgical Oncology.

BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy

I. Bièche, B. Asselain, M. Marty, 2016, Breast Cancer Research and Treatment.

Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer.

A. Vincent-Salomon, Y. Rycke, F. Bidard, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Histological Detection of Minimal Metastatic Involvement in Axillary Sentinel Nodes: A Rational Basis for a Sensitive Methodology Usable in Daily Practice

A. Vincent-Salomon, B. Sigal-Zafrani, X. Sastre-Garau, 2002, Modern Pathology.

Breast inflammatory gigantomastia in a context of immune-mediated diseases.

N. Brousse, C. Balleyguier, B. Eymard, 2005, The Journal of clinical endocrinology and metabolism.

[Ectopic breast cancer of the axilla].

S. Aractingi, E. Amsler, E. Marinho, 2002, Annales de dermatologie et de venereologie.

Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology

J. Peterse, I. Ellis, C. Elston, 2004, Journal of Clinical Pathology.

Antigen‐independent accumulation of activated effector/memory T lymphocytes into human and murine tumors

A. Vincent-Salomon, J. Klijanienko, X. Sastre, 2006, International journal of cancer.

Analysis of correlation between mitotic index, MIB1 score and S-phase fraction as proliferation markers in invasive breast carcinoma. Methodological aspects and prognostic value in a series of 257 cases.

A. Vincent-Salomon, J. Klijanienko, C. Elie, 2004, Anticancer research.

Gain-of-function Prolactin Receptor Variants Are Not Associated With Breast Cancer and Multiple Fibroadenoma Risk.

S. Vacher, I. Bièche, P. Camparo, 2016, The Journal of clinical endocrinology and metabolism.

Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay

A. Vincent-Salomon, R. Rouzier, F. Reyal, 2016, PloS one.

Correction: Respective Prognostic Value of Genomic Grade and Histological Proliferation Markers in Early Stage (pN0) Breast Carcinoma

A. Vincent-Salomon, M. Bollet, F. Reyal, 2012, PLoS ONE.

Tumor aromatase expression as a prognostic factor for local control in young breast cancer patients after breast-conserving treatment

M. Bollet, N. Servant, G. Almouzni, 2009, Breast Cancer Research.

HER2 gene status assessment in micrometastatic cells in bone marrow (BM) of breast cancer patients by fluorescence in situ hybridization (FISH)

J. Thiery, A. Vincent-Salomon, J. Pierga, 2004 .

HER2 gene status assessment in micrometastatic cells in bone marrow (BM) of breast cancer patients by fluorescence in situ hybridization (FISH).

J. Thiery, A. Vincent-Salomon, H. Magdelenat, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Breast cancer survivors' perceived medical communication competence and satisfaction with care at the end of treatment

J. Kop, A. Brédart, S. Dolbeault, 2015, Psycho-oncology.

Long-Term Prognostic Performance of Ki 67 Rate in Early Stage , pT 1pT 2 , pN 0 , Invasive Breast Carcinoma

A. Vincent-Salomon, M. Bollet, F. Reyal, 2013 .

Lobular phenotype related to occult-metastatic spread in axillary sentinel node and/or bone marrow in breast carcinoma.

A. Vincent-Salomon, J. Klijanienko, F. Bidard, 2009, European journal of cancer.

Breast lesions: quantitative elastography with supersonic shear imaging--preliminary results.

M. Fink, M. Tanter, J. Gennisson, 2010, Radiology.

[Breast cancer in the early stage].

R. J. Jones, M. Espié, G. Giaccone, 2012, Gan no rinsho. Japan journal of cancer clinics.

Epithelial atypia: a marker risk of concomitant or subsequent breast carcinoma?

A. Vincent-Salomon, V. Brouste, I. de Mascarel, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance

Anne Vincent-Salomon, Valérie Choesmel, J. Thiery, 2004, Breast Cancer Research.

Histological margin assessment for breast ductal carcinoma in situ: precision and implications

A. Vincent-Salomon, B. Sigal-Zafrani, M. Meunier, 2004, Modern Pathology.

High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategies

A. Vincent-Salomon, M. Bollet, J. Pierga, 2008, British Journal of Cancer.

Bilateral Poly Implant Prothèse Implant Rupture: An Uncommon Presentation

F. Reyal, B. Sigal-Zafrani, A. Fitoussi, 2013, Plastic and reconstructive surgery. Global open.

Improving the definition of tumor bed boost with the use of surgical clips and image registration in breast cancer patients.

Nathalie Fournier-Bidoz, Tarek Hijal, Youlia M Kirova, 2010, International journal of radiation oncology, biology, physics.

Identifying trajectory clusters in breast cancer survivors’ supportive care needs, psychosocial difficulties, and resources from the completion of primary treatment to 8 months later

O. Merdy, J. Hardouin, A. Brédart, 2015, Supportive Care in Cancer.

Responses to concurrent radiotherapy and hormone-therapy and outcome for large breast cancers in post-menopausal women.

M. Bollet, P. Cottu, A. Fourquet, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Early Breast Cancer (Stage I and II): Tailored Radiotherapy for Very Young Women

B. Sigal-Zafrani, A. Fourquet, A. Rochefordière, 2006 .

Breast and ovarian cancer risk management in a French cohort of 158 women carrying a BRCA1 or BRCA2 germline mutation: patient choices and outcome

B. Asselain, D. Stoppa-Lyonnet, A. Tardivon, 2012, Familial Cancer.

Characterization of Breast Cancer Preclinical Models Reveals a Specific Pattern of Macrophage Polarization

G. Massonnet, A. Nicolas, S. Roman-Roman, 2016, PloS one.

MRI for surgical planning in patients with breast cancer who undergo preoperative chemotherapy.

M. Meunier, C. Nos, F. Thibault, 2004, AJR. American journal of roentgenology.

ATIP3, a novel prognostic marker of breast cancer patient survival, limits cancer cell migration and slows metastatic progression by regulating microtubule dynamics.

A. Vincent-Salomon, O. Delattre, F. André, 2013, Cancer research.

Preoperative radio-chemotherapy in early breast cancer patients: long-term results of a phase II trial.

M. Bollet, F. Reyal, V. Diéras, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Pathological response to preoperative concurrent chemo-radiotherapy for breast cancer: results of a phase II study.

M. Bollet, L. Gambotti, V. Diéras, 2006, European journal of cancer.

Hormone Replacement Therapy after Prophylactic Adnexectomy

D. Stoppa-Lyonnet, B. Sigal-Zafrani, S. Dolbeault, 2005, Hereditary cancer in clinical practice.

Prediction of axillary lymph node status in male breast carcinoma.

A. Vincent-Salomon, R. Rouzier, F. Reyal, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Extensive pure ductal carcinoma in situ of the breast: identification of predictors of associated infiltrating carcinoma and lymph node metastasis before immediate reconstructive surgery.

M. Bollet, F. Reyal, X. Sastre-Garau, 2014, Breast.

Medico-economic impact of MSKCC non-sentinel node prediction nomogram for ER-positive HER2-negative breast cancers

A. Vincent-Salomon, R. Rouzier, F. Reyal, 2017, PloS one.

[Standards, Options and Recommendations for the management of ductal carcinoma in situ of the breast (DCIS): update 2004].

L. Mauriac, A. Tardivon, B. Sigal-Zafrani, 2005, Bulletin du cancer.

Validation and Limitations of Use of a Breast Cancer Nomogram Predicting the Likelihood of Non–Sentinel Node Involvement After Positive Sentinel Node Biopsy

Y. Rycke, P. Fréneaux, M. Bénamor, 2007, Annals of Surgical Oncology.

[Breast-conserving therapy of breast cancer].

A. Fourquet, C. Nos, K. Clough, 2004, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Summary version of the standards, options and recommendations for nonmetastatic breast cancer (updated January 2001)

R. Gilles, M. Dilhuydy, L. Mauriac, 2003, British Journal of Cancer.

Pathologic Response to Short Intensified Taxane-free Neoadjuvant Chemotherapy in Patients with Highly Proliferative Operable Breast Cancer

A. Vincent-Salomon, J. Pierga, V. Diéras, 2012, American journal of clinical oncology.

A Multicenter Randomized Phase II Study of Sequential Epirubicin/Cyclophosphamide Followed by Docetaxel with or without Celecoxib or Trastuzumab According to HER2 Status, as Primary Chemotherapy for Localized Invasive Breast Cancer Patient.

M. Mathieu, M. Marty, J. Pierga, 2009 .

Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage.

A. Vincent-Salomon, M. Bollet, B. Asselain, 2009, International journal of radiation oncology, biology, physics.

Inter-laboratory quality control for hormone-dependent gene expression in human breast tumors using real-time reverse transcription-polymerase chain reaction.

I. Bièche, B. Asselain, V. Bécette, 2004, Endocrine-related cancer.

Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer.

A. Vincent-Salomon, M. Marty, F. Bidard, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Cost comparison of axillary sentinel lymph node detection and axillary lymphadenectomy in early breast cancer. A national study based on a prospective multi-institutional series of 985 patients 'on behalf of the Group of Surgeons from the French Unicancer Federation'.

P. Colombo, P. Rouanet, P. Gimbergues, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Quality of life in a randomized control trial? Comments concerning MA 17.

B. Asselain, A. Brédart, S. Dolbeault, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Familial Breast Cancer: Clinical Response to Induction Chemotherapy or Radiotherapy Related to BRCA1/2 Mutations Status

B. Asselain, D. Stoppa-Lyonnet, A. Fourquet, 2009, American journal of clinical oncology.

Intratumoral heterogeneity of HER2/neu expression and its consequences for the management of advanced breast cancer.

A. Vincent-Salomon, J. Pierga, V. Diéras, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Genomic hallmarks of homologous recombination deficiency in invasive breast carcinomas

O. Mariani, A. Vincent-Salomon, M. Stern, 2016, International journal of cancer.

Tumor and Stem Cell Biology ATIP 3 , a Novel Prognostic Marker of Breast Cancer Patient Survival , Limits Cancer Cell Migration and Slows Metastatic Progression by Regulating Microtubule Dynamics

A. Vincent-Salomon, O. Delattre, D. Braguer, 2013 .

Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage.

A. Vincent-Salomon, M. Bollet, B. Asselain, 2009, International journal of radiation oncology, biology, physics.